Jazz Pharmaceuticals Announces Second Quarter 2019 Financial Results

Go back to Jazz Pharmaceuticals Announces Second Quarter 2019 Financial Results
JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) Delayed: 240.07 -6.74 (2.73%)
Previous Close $246.81    52 Week High $160.00 
Open $240.00    52 Week Low $95.80 
Day High $244.71    P/E 44.62 
Day Low $239.11    EPS $5.38 
Volume 467,907